SECZ: Analysts Rush In as Shorts Dig Deeper

Securitize Corp. has doubled in price over the past month while simultaneously attracting the most aggressive short-selling pressure in its history — a tension that the Street is now scrambling to price.

The analyst community moved fast this week. Cantor Fitzgerald initiated coverage on September 21 with an Overweight and a $21.20 target — the most bullish call on the stock by a wide margin. Rosenblatt lifted its target from $11 to $13 the same day, maintaining Buy. Both moves followed a StoneX raise to $12 from $10 three days earlier. The consensus is uniformly constructive: four Buy-equivalent ratings, mean target $13.70, against a $13.00 close. The bull case rests on Securitize's lead position in real-world asset tokenization, an $11.3 trillion addressable market by 2030, and potential tailwinds from the CLARITY Act. The bear case is equally concrete — revenue dependence on a handful of platform partners, recent financial underperformance, and a valuation that leaves little room for execution slips.

The lending market tells a different story from the analysts. Short interest has more than doubled in a week, climbing from roughly 3.0 million shares to an estimated 8.0 million by September 22 — a 168% increase. Cost to borrow remains extreme. It was near 14% as recently as September 18. It hit 133% on September 21, and pulled back only modestly to 114.5% on September 22 — still up 739% on the week. At that rate, borrowing SECZ for a full year costs more than the share itself. Availability remains very tight at 8.1%, meaning for every twelve shares already out on loan, just one remains in the lending pool. The previous note published Tuesday captured the sharpest moment of this stress — availability briefly hit 0.06% on September 21, the tightest print in the stock's 52-week record. That episode has partially unwound, but the borrow market is not close to normalised.

Options positioning adds another layer of divergence. The put/call ratio jumped to 0.27 on September 22 — nearly four standard deviations above its 20-day average of 0.15. That is an unusually large move toward downside protection in a market where calls have dominated for months. It sits below the 52-week high of 0.46, so it does not signal outright panic — but the direction is a notable shift after weeks of near-pure call dominance. The combination of a near-zero availability spike, a cost-to-borrow explosion, and a sudden PCR move suggests that new shorts are not just building positions — they are paying a steep price to do so, and some existing longs are buying insurance simultaneously.

Ownership context matters here. Both Blockchain Capital and CEO Carlos Domingo filed Schedule 13D disclosures in July — activist-classified stakes at 6.0% and 5.4% respectively. A founder and a specialist crypto investor both on the 13D register is a structural anchor to the ownership base; these are not traders. ARK Investment Management also holds a position, last reported at end of August. All three were established holders before the stock's 112% one-month rally — their presence does not explain the recent price action, but it does suggest a concentrated, conviction-heavy core that is unlikely to be the source of the selling pressure. Insider activity in the record is compensation awards rather than open-market transactions, so it carries limited directional signal.

The next scheduled catalyst is earnings on November 12. The recent earnings history is volatile — a 16% one-day gain on September 4, followed by a 23% to 29% single-day drop on August 12 and 13. The setup heading into that print will depend heavily on whether the borrow market stays stressed or normalises, and whether the Cantor $21.20 target — which implies 63% upside from here — pulls additional analyst coverage or institutional buying that changes the availability dynamic.